Dialogues in Clinical Neuroscience

Dialogues in Clinical Neuroscience is a quarterly peer-reviewed journal published by Taylor & Francis on behalf of the World Federation of Societies of Biological Psychiatry, covering clinical neuroscience. Founded in 1999, it serves as an interface between clinical neuropsychiatry and the neurosciences, with a 2025 impact factor of 5.1, indexed in SCIE.《临床神经科学对话》(Dialogues in Clinical Neuroscience, 简称 DCNS)是由 Taylor & Francis 代表世界生物精神病学联合会出版的季刊同行评审期刊,涵盖临床神经科学。该刊创刊于 1999 年,是临床神经精神病学与神经科学之间的桥梁,2025 年影响因子为 5.1,被 SCIE 收录。

Scope

The journal's stated aim is to serve as an interface between clinical neuropsychiatry and the neurosciences by providing state-of-the-art information on clinical, biological, and therapeutic aspects, with its official scope covering:刊物官方宗旨为通过提供临床、生物学与治疗方面的前沿信息,成为临床神经精神病学与神经科学之间的桥梁,官方声明的征稿范围包括:

History

Editors

The journal is led by a chief editor supported by an editorial board:该刊由主编领导,编委会协助工作: